Pallas Health vs Alan Meds

Shoppers who want the whole cost stated before signup, one price at every dose, and the option of a brand-name drug or a tablet on the same account.

Reasons to consider it

• +Both molecules are priced publicly and stay the same at every dose: $199 or $299 every 4 weeks after a $139 or $179 first month
• +The annual plan brings the average down to $139 a month for semaglutide and $239 for tirzepatide
• +Brand-name Wegovy (pen or pill), Foundayo, Zepbound, Ozempic and Mounjaro are sold cash-pay, and compounded semaglutide also comes as a daily tablet

What to weigh up

• −Billing every 4 weeks is 13 charges a year, not 12, so a year costs more than 12 times the figure
• −Brand-name drugs are full cash-pay prices ($1,069 to $1,349 a month) with no insurance routing
• −Once a prescription is issued, that cycle's order is final and isn't prorated

Budget-first shoppers who want the lowest sema price plus an oral route nationwide.

Reasons to consider it

• +$99 semaglutide and $145 tirzepatide — among the cheapest disclosed prices we track
• +Nationwide all-50 access with an oral/sublingual option
• +Both molecules published for straightforward cost modeling

What to weigh up

• −Not LegitScript-certified — oversight harder to verify
• −Compounded only — no brand-name access

Regulatory note: the FDA issued a warning letter to Alan Health Technologies Inc. dba Alan in February 2026. We still list and link to Alan Meds; you should know the letter is on the public record before you decide.